Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000US6080753 Stimulating nerve growth with immunophilins
06/27/2000US6080752 For treating condition which requires antagonism of a dopamine receptor such as psychtic condition
06/27/2000US6080751 Administering 9-nitro-20(s)-camptothecin and/or 9-amino-20(s)-camptothecin for treating panceatic cancer in humans
06/27/2000US6080750 For prophylaxis and treatment of diseases caused by infection by rotavirus
06/27/2000US6080748 Treating mast cell mediated hypersensitivity reaction by administering a jak-3 kinase inhibitor compound
06/27/2000US6080747 JAK-3 inhibitors for treating allergic disorders
06/27/2000US6080746 Methods and compositions for the prophylaxis and treatment of cytomegalovirus infections
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/27/2000US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
06/27/2000US6080742 Substituted benzamides
06/27/2000US6080741 Arglabin compounds and therapeutic uses thereof
06/27/2000US6080740 Spiro-ketal derivatives and their use as therapeutic agents
06/27/2000US6080739 Colchicine-skeleton compounds, their use as medicaments and compositions containing them
06/27/2000US6080738 Heterocyclic amide compounds and medicinal uses thereof
06/27/2000US6080737 Uveitis remedy
06/27/2000US6080736 Treat or prevent anxiety or anxiety disorders either alone or in conjunction with psychotherapy and/or antidepressants
06/27/2000US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
06/27/2000US6080732 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
06/27/2000US6080731 Dinucleoside-5', 5'-pyrophosphates administered to treat HIV
06/27/2000US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds
06/27/2000US6080728 Inhibiting tumor growth
06/27/2000US6080726 Anti-viral and immuno stimulator polynucleotide duplex and use thereof
06/27/2000US6080588 Administering derivative to subject to inhibit or prevent disease associated with binding of antibodies to dna; treatment of systemic lupus erythematosus and inflammatory glomerulonephritis
06/27/2000US6080575 Isolated nucleic acid construct for expressing a biologically active substance which is activated by an enzyme released from mammalian cells; for target cell-specific therapy for tumors and inflammation
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080538 Plasma like solution and methods of use
06/27/2000US6080431 Nutritional mineral supplements comprising calcium citrate malate and vitamin d; for increasing bone growth and for treating age-related bone loss in humans and animals
06/27/2000US6080428 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
06/27/2000US6080427 Uncoated compressed tablets for oral administration by swallowing, chewing or drinking in water; containing microcrystalline cellulose, guar gum; polyvinylpyrrolidone, silica sol, dibasic calcium phoshate and mannitol
06/27/2000US6080422 Administering a lipid acceptor selected from the group consisting of large liposomes comprised of phospholipids substantially free of sterol and small acceptors. prevention of restenosis during revascularization
06/27/2000US6080416 A hydroalcohol mixture of stearoxytrimethylsilane, cyclomethicone, cetyl lactate and a c1-15 alkyl lactate and ethyh, isopropyl and/or propyl alcohol and/or water; nontacky; moisturizing; protective coatings; skins
06/27/2000US6080409 Immunostimulatory method
06/27/2000US6080397 Infusion or surgical rinse colloidal solutions of polyvinylpyrrolidone (pvp) of given molecular weight; free of impurities and high molecular weight pvp, and having low: amine content, peroxide, and solvent; nonallergenic
06/27/2000US6080395 Method and composition for topical treatment of damaged tissue using histamine as active ingredient
06/27/2000US6080394 Nonaqueous polar solvent phase dispersed in silicon oil continuous phase by a crosslinked elastomeric silicone polyether emulsifier swollen by the silicone oil; carrier of polar active ingredients with improved chemical stability
06/27/2000US6080388 Cosmetic and dermatological sunscreen formulations containing triazine derivatives and alkane carboxylic acids
06/27/2000US6080385 Oxidative metabolism in smooth muscle cells: methods and materials relating thereto
06/27/2000US6080383 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
06/27/2000CA2188427C Neurotransmitter release enhancers
06/27/2000CA2131021C Use of injectable biomaterials for the repair and augmentation of the anal sphincters
06/27/2000CA2122897C Novel pharmaceutically active flavilium compounds
06/27/2000CA2058822C Antibacterial agents
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/27/2000CA2013960C Substituted dibenzofurans and methods of using same
06/27/2000CA2001129C Tumour-inhibiting saccharide conjugates
06/24/2000CA2296193A1 Powdered dextrose and procedure for preparing it
06/23/2000CA2596416A1 Methods of extended use oral contraception
06/23/2000CA2257001A1 Method and formulations for prevention of infection of mucosae and/or skin and development of a vaginal/ano-rectal applicator for the delivery of topical formulations
06/22/2000WO2000036131A1 Synthetic nucleic acid particle
06/22/2000WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000035943A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035938A1 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035934A1 Macrolide intermediates in the preparation of clarithromycin
06/22/2000WO2000035933A1 Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same
06/22/2000WO2000035930A1 Vanadium compounds for treating cancer
06/22/2000WO2000035924A1 Camptothecin analogs and methods of preparation thereof
06/22/2000WO2000035922A1 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)quinoxalin-5(6h)one derivates being 5ht2c agonists
06/22/2000WO2000035921A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000WO2000035920A2 4,5-azolo-oxindoles
06/22/2000WO2000035919A2 Quinoline derivatives
06/22/2000WO2000035917A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035914A1 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
06/22/2000WO2000035911A1 Heteroaryl-cyclic acetals
06/22/2000WO2000035910A1 Derivative of paroxetine
06/22/2000WO2000035909A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035904A1 INHIBITORS OF β-LACTAMASES AND USES THEREFOR
06/22/2000WO2000035892A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035884A1 Control of arthropods in animals
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/22/2000WO2000035878A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000WO2000035874A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
06/22/2000WO2000035873A1 Process for preparation of paroxetine maleate
06/22/2000WO2000035871A1 Lactams
06/22/2000WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors
06/22/2000WO2000035867A1 Novel ligands of nuclear receptor
06/22/2000WO2000035865A2 Tubulin-binding agents
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035862A1 Amido polybiguanides and the use thereof as antimicrobial agents
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035856A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035848A1 Aldose reductase inhibitors and pharmaceutical compositions
06/22/2000WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035486A1 Soluble compositions of toremifene
1 ... 6294 6295 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 ... 7860